COVID-19, Hydroxychloroquine & the Patients Who Need It

Representing Those Who Need Critical Drugs During the Coronavirus Outbreak

Hydroxychloroquine is a pharmaceutical drug commonly used to treat autoimmune diseases such as rheumatoid arthritis and lupus. It has made a splash in recent headlines for two reasons: President Donald Trump’s touting of the drug’s effectiveness against COVID-19 (despite shaky evidence), and the sudden shortage of the drug that became apparent just days later.

For patients suffering from lupus – a serious and incurable autoimmune disease where the immune system attacks the body and can cause serious or fatal damage to vital organs – shortages of hydroxychloroquine, which can combat lupus symptoms, are a frightful prospect. This is especially so for people like a Los Angeles-area woman who was denied a refill of the drug by Kaiser Permanente despite taking it for longer than a decade to treat her lupus symptoms.

Many other patients may soon find themselves in similar situations and may need to seek legal recourse to challenge their healthcare providers when they prescriptions for hydroxychloroquine are denied. Other patients may soon see drastic increases in the cost of their medications like hydroxychloroquine and so may need to take legal action to protect their rights. At Dorros Law, our healthcare law practice can assist clients who are experiencing legal difficulty or challenges related to COVID-19, hydroxychloroquine, and the patients who need it in Los Angeles.

If you need legal help regarding this issue or another like it, reach out to our firm onlineor call (310) 935-0621 for assistance. Someone from Dorros Law will arrange a consultation between you and one of our healthcare law attorneys who can help.